DepressionIMAGINE-PNCT05507385
Imagine a Brighter Future: An Intervention to Improve Positive Emotions in Young People
A study testing IMAGINE-POSITIVE in people with Depression and Anhedonia, run by King's College London at 1 site in United Kingdom.
Trial summary
Depression is a common mental health problem that often begins during adolescence. Onset during adolescence can be disruptive to schoolwork and social relationships and if left untreated can lead to recurrence during adulthood, as well as the development of other mental health problems. Read more about this study
- Who is it for?
- Ages 14 to 19 years
- Conditions the study is for
- Depression, Anhedonia
- What is being tested?
- IMAGINE-POSITIVE
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 0 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- Sep 2022to 30 Jun 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 14 to 19 years
- All sexes
- No healthy volunteers
- Child, Adult
Who may be able to join
- Aged 14-19
- Informed consent
- Willing and able to engage in psychological therapy and complete assessments
- scoring above clinical cut-off on the MFQ (33 items; clinical cut-off ≥20, and showing high symptoms of anhedonia, as measured by the SHAPS ( 14 items; abnormal level of hedonic tone>2).
Who cannot join
- Diagnosis of learning disability (but not difficulty e.g. dyslexia), diagnosis of Autism Spectrum Disorder, or significant head injury, neurological disorder or epilepsy
- Unable to fluently communicate in spoken English
- Unable to give informed consent
- High levels of current risk
- Currently receiving therapy (including school counselling)
- Experiencing psychotic symptoms or depressed in the postnatal period (participants with co-morbid physical illness or non-psychotic disorders such as anxiety will not be excluded)
Trial locations and contacts
1 site in 1 country.
About this study
Official title: A Brief Intervention Targeting Anhedonia in Adolescents: a Feasibility Randomised Controlled Trial
Depression is a common mental health problem that often begins during adolescence. Onset during adolescence can be disruptive to schoolwork and social relationships and if left untreated can lead to recurrence during adulthood, as well as the development of other mental health problems. Current treatments for depression (for both adults and young people) largely focus on reducing low mood and do not effectively tackle the other hallmark symptom of depression, anhedonia, which is characterised as a loss of enjoyment/ pleasure for previously enjoyed activities. Anhedonia is associated with increased risk of suicidality, so should be an important treatment target. Whilst some adult treatments are beginning to address anhedonia, little research has focussed on young people. It cannot be assumed that adult treatments will work identically in young people, particularly s their brains are still maturing compared to adults. The aim of this study is to complete a randomised feasibility trial, to see if it is possible to run a brief talking therapy for anhedonia in adolescent depression, by targeting one promising cognitive factor known to contribute to low positive affect: positive future mental imagery
Read the detailed description
The goal of the project is to develop a brief, manualised intervention for adolescent depression that targets anhedonia through harnessing the ability to imagine positive events. This intervention is designed to be delivered in the school environment by practitioners without extensive training. A feasibility randomised controlled trial (RCT) will be conducted by the doctoral student in the proposed project to assess the acceptability of this intervention in schools.
Principal Research Questions:
The primary question is whether a brief, structured intervention to reduce anhedonia symptomatology in depressed adolescents is feasible and acceptable. This trial will inform whether a full-scale efficacy trial is warranted and provide estimates of effect sizes. The trial's primary aims are:
- To evaluate recruitment and retention for a future efficacy RCT, for example recruitment rates for schools and participants, attrition rates and outcome measure completion.
- To gather descriptive data on symptom change to inform future estimates of the number of participants required for a fully powered efficacy RCT.
Background:
Depression is a major public health concern, associated with severe and long-lasting impairment. Many cases of depression start in adolescence with adolescent-onsets associated with greater illness burden than adult-onsets. Whilst psychological intervention in adolescence may prevent the persistence of depression into adulthood and its debilitating consequences, these are rarely available. There is also a consistent failure to produce well-replicated efficacious psychological and pharmacological treatments in adolescent depression. In adults, treatment innovation techniques have tried to focus on specific features, such as anhedonia, that are associated with severity and treatment response. Anhedonia, a loss of pleasure or lack of reactivity to pleasurable stimuli, is a hallmark feature of depression. It is associated with brain reward systems and, in youth, predicts illness severity, suicidality and poor treatment response better than other symptoms of depression. Given these findings and that brain reward systems underlying anhedonia are maturing and stabilising in adolescence focussing on the up-regulation of positive emotion during this developmental juncture could be a beneficial therapeutic approach.
Traditionally, psychological interventions for depression target negative affect in the present and/or past. However, potential deficits in processing positive information, in particular positive future-directed cognitions, may be crucial to alleviate anhedonia and produce enhanced treatment response. Mental imagery is suggested to be a powerful tool to promote changes in positive prospective cognitions. In adolescence, this approach could be particularly beneficial as it is a period when future orientation increases and when individuals rely more on imagery for processing and skill acquisition than in adulthood. Although research in this area in adolescent depression is limited, our findings suggest that having more vivid positive future imagery can protect against depressive symptoms in youth following a recent negative life event. Through a National Institute for Health and Care Research (NIHR) funded project, the investigators have developed a novel brief therapy manual and implementation protocol for adolescents using co-design methodology (Research Ethics Sub-Committee ref: HR-15/16-3548; Project ID: 14884). This targets mental imagery in general (rather than positive future mental imagery, in particular) to attenuate depression symptoms. A case series of 9 participants suggests that this intervention is acceptable and may have clinical utility. However, this intervention targets depression generally rather than anhedonia specifically and has only been delivered by an experienced child clinical psychologist. Therefore, the aim of this project is to develop a brief, manualised intervention that targets anhedonia in adolescents with depression, which can be delivered in schools by practitioners without extensive training.
Intervention:
The investigators will adapt our existing therapy manual to create a manualised protocol that more specifically targets positive future imagery to reduce anhedonia. The existing intervention is a four-session programme involving memory specificity training to increase specificity and access to autobiographical memories, imagery re-scripting to reduce distress from negative images and building of positive images. In order to tackle anhedonia more specifically, the investigators will replace negative imagery re-scripting with elements that target up-regulation of positive emotion and expand and elaborate on positive future imagery generation. These changes will also be informed through discussion with other experts and service-user consultants.
Feasibility randomised controlled trial: As this study will assess feasibility and not efficacy, a power calculation to determine sample size is not appropriate. The sample size (n=32, 16 in each arm) was determined with reference to good practice recommendations. The control condition will be 'non-directive supportive therapy', consisting of individual sessions to provide empathy and emotional support, discussion of participant-initiated options for addressing problems and monitoring of depression. The number and frequency of sessions will be matched across groups to control for non-specific factors contributing to change (e.g. passage of time, rapport with an empathic adult). Blind pre/post assessments will be conducted for all participants.
- Conditions
- Depression, Anhedonia
- Being tested
- IMAGINE-POSITIVE, Control
- Keywords
- Adolescence, Depression, Anhedonia, Mental Imagery
- Medical subject headings
- Depression, Anhedonia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
IMAGINE-POSITIVEBehavioural
The intervention will combine aspects of Memory Specificity Training (MeST), which includes information about the links between memories and emotions, with Positive Prospective Mental Imagery (PPMI), to increase vividness and savouring of positive future images, in order to harness positive affect. IMAGINE-PA will follow a treatment manual and delivery will be accompanied by a therapy workbook.
ControlBehavioural
Non-directive supportive therapy (NDST) consists of individual sessions, with an empathetic, emotionally supportive practitioner and provides non-directive problem solving and monitoring. Using NDST will control for factors that may contribute to change, which are not active components e.g. speaking to an empathetic therapist. NDST will follow treatment guidelines.
| Study group | Role | What they receive |
|---|---|---|
| Intervention: IMAGINE-P | Experimental | Experimental intervention: IMAGINE-POSITIVE targeting positive affect (IMAGINE-P):
The intervention will combine aspects of Memory Specificity Training (MeST), which includes information about the links between memories and emotions, with Positive Prospective Mental Imagery (PPMI). Receives: Behavioral: IMAGINE-POSITIVE |
| Control: | Active comparator | Control intervention: Non-directive supportive therapy (NDST) consists of individual sessions, with an empathetic, emotionally supportive practitioner and provides non-directive problem solving and monitoring. Using NDST will control for factors that may contribute to change, which are not active components e.g. speaking to an empathetic therapist. NDST will follow treatment guidelines. Receives: Behavioral: Control |
What is being measured
The primary outcome is the main question the study is designed to answer.
Feasibility outcome - 1: Uptake by schools
A percentage will be calculated for: the number of schools that express interest in the study divided the number of schools that do take part.
Measured: Through study completion, an average of 9 months
Feasibility outcome - 2: Uptake by participants
This will outcome will be assessed at the different stages of participant uptake:
- the number of participants that completed the screen questionnaire divided by the number of students who received the screen questionnaire
- the number of participants that accepted the invitation to pre-assessment divided by the number of participants that were eligible for pre-assessment from the screen
- The number of participants randomised to intervention divided by the number of participants that completed the pre-assessment
- The number of participants that completed the post-assessment divided by the number of participants that were randomised to intervention
Measured: Through study completion, an average of 9 months
Feasibility outcome - 3: Intervention completion
The number of participants successfully completing the intervention
Measured: Through study completion, an average of 9 months
Feasibility outcome - 4: Intervention drop-out
The number of participants that drop-out and the reasons for dropping out
Measured: Through study completion, an average of 9 months
Feasibility outcome - 5: Time Period
Time needed to collect and analyse data
Measured: Through study completion, an average of 9 months
Feasibility outcome - 6: Data completeness at pre-assessment
Data completeness for each questionnaire at pre-assessment
Measured: Through study completion, an average of 9 months
Feasibility outcome - 7: Missing Data at pre-assessment
Data missing and reasons for missing data at pre-assessment
Measured: Through study completion, an average of 9 months
Feasibility outcome - 8: Data completeness at post-assessment
Data completeness for each questionnaire at post-assessment
Measured: Through study completion, an average of 9 months
Feasibility outcome - 9: Missing Data at post-assessment
Data missing and reasons for missing data at post-assessment
Measured: Through study completion, an average of 9 months
Feasibility outcome - 10: Data completeness at follow-up assessment
Data completeness for each questionnaire at follow-up assessment
Measured: Through study completion, an average of 9 months
Feasibility outcome - 11: Missing Data at follow-up assessment
Data missing and reasons for missing data at follow-up assessment
Measured: Through study completion, an average of 9 months
Feasibility outcome - 12: Unexpected adverse effects
The number and nature of unexpected adverse effects will be recorded
Measured: Through study completion, an average of 9 months
Acceptability of the intervention - 1: Open questions for qualitative feedback of the programme
Qualitative questions on the feedback questionnaire:
- What did you think of the programme?
- Was there anything that made you more likely or less likely to take part in the programme?
- How did you find completing the programme at school?
- Was there anything about the programme that you really liked?
- Was there anything about the training programme that you really didn't like?
- What was the most important thing about the programme for you?
- Would you recommend this to others who are experiencing difficulties with mood and self-esteem? If so why? Or why not?
- Is there anything else you'd like to say about this programme?
Measured: Post-intervention (within 2 weeks of post intervention)
Acceptability of the intervention - 2: Satisfaction with the programme
Participants indicate how satisfied they were with the programme on a 5-point scale; minimum score: 1; maximum score 5. Higher scores indicate better outcome.
Measured: Post-intervention (within 2 weeks of post intervention)
Acceptability of the intervention - 3: Feedback on the number of sessions in the programme
Participants rate what they thought about the number of session on a 5-point scale. 1 = I would have liked 2+ less; 2= I would have liked 1-2 less; 3= I was happy with the number of sessions; 4= I would have liked 1-2 more; 5= I would have liked 2+ more. Minimum score: 1; maximum score 5.
Measured: Post-intervention (within 2 weeks of post intervention)
Acceptability of the intervention - 4: Extend the programme has helped
Participants rate the extent to which the programme helped them on a 5-point scale. Minimum score: 1; maximum score: 5; higher scores indicate better outcome.
Measured: Post-intervention (within 2 weeks of post intervention)
Acceptability of the intervention - 5: Recommend the programme to a friend
Participants rate if they would recommend the programme to a friend on a 5-point scale. 1= no, definitely not; 2= probably not; 3 = unsure; 4 = yes, probably; 5 = yes, definitely. Minimum score: 1; maximum score 5; higher scores indicate better outcome.
Measured: Post-intervention (within 2 weeks of post intervention)
Secondary outcomes (10)
Mood and Feelings Questionnaire
A 33-item measure of low mood in young people rated on a 3-point Likert scale. Minimum score: 0; maximum score: 66; higher scores indicate worse outcome.
Measured: Pre-intervention (baseline), post-intervention (within 2 weeks of post intervention), 3 month follow up
Snaith-Hamilton Pleasure Scale
A measure of anhedonia, consisting of 14 items rated on a 4-point Likert scale. Minimum score: 0; maximum score: 56; higher scores indicate worse outcome.
Measured: Pre-intervention (baseline), post-intervention (within 2 weeks of post intervention), 3 month follow up
Positive and Negative Affect Schedule
A self-report measure of negative and positive affect and consists of 20-items (10 negative items, 10 positive items) rated on a 5-point Likert scale. On each subscale (negative and positive) minimum score: 10; maximum score: 50. Higher scores indicate greater negative affect and greater positive affect.
Measured: Pre-intervention (baseline), post-intervention (within 2 weeks of post intervention), 3 month follow up
The Prospective Imagery Task
A measure of imagery vividness. It has been adapted for use in young people by (Pile et al., 2018). Fourteen scenarios (7 positive and 7 negative) are presented to participants (e.g. "You will achieve something you wanted to"), who are asked to imagine each happening to them and then rate this mental image on a 5-point scale; 'No image at all' (score of 1) to 'Very clear and detailed' (score of 5). Higher scores indicate greater vividness of future imagery.
Measured: Pre-intervention (baseline), post-intervention (within 2 weeks of post intervention), 3 month follow up
Autobiographical Memory Task
A measure of memory specificity. Participants will be given an example of a specific memory and then asked to give a specific memory to ten cue words (five positive; five negative).
Measured: Pre-intervention (baseline), post-intervention (within 2 weeks of post intervention), 3 month follow up
Screen for Child Anxiety Related Disorders
A self-report measure of anxiety, consisting of 41 items rated on a 3-point Likert scale. Minimum score: 0; maximum score: 82; higher scores indicate worse outcome.
Measured: Pre-intervention (baseline), post-intervention (within 2 weeks of post intervention), 3 month follow up
Rosenberg Self Esteem Scale
A 10-item self-report measure of self-worth, rated on a 4-point Likert scale. Minimum score: 0; maximum score: 30; high scores indicate better outcome.
Measured: Pre-intervention (baseline), post-intervention (within 2 weeks of post intervention), 3 month follow up
Children's Response Style Questionnaire
A 25-item self report measure of response styles, rated on a 4-point scale; 'Almost never' (score of 0) to 'Almost always (score of 3). There are with three response style subscales: rumination, distraction and problem solving. Minimum scores on each subscale is 0. Maximum scores for each subscale: rumination: 39, distraction: 21, problem solving: 15. Higher scores indicate a greater tendency to engage in that response style.
Measured: Pre-intervention (baseline), post-intervention (within 2 weeks of post intervention), 3 month follow up
Self Compassion Scale
A 26-item self-report measure of self compassion, rated on a 5-point scale; 'Almost never' (a score of 1) to 'Almost always' (a score of 5). There are 6 subscales of self-compassion: self-kindness, self-judgement, common humanity, isolation, mindfulness and over identification. There is reverse scoring for subscales of self-judgement, isolation and over identification, as these indicate poorer self-compassion. The Self Compassion Scale is scored by computing a total self-compassion score. This total self-compassion score is calculated by first reverse scoring the negative subscales, then taking a mean of each subscale and then taking an average of the 6 subscale means). Self Compassion Scale Norms: 1.0-2.49 = low self-compassion; 2.5-3.5 = moderate self-compassion; 3.51-5.0 = high self-compassion.
Measured: Pre-intervention (baseline), post-intervention (within 2 weeks of post intervention), 3 month follow up
Child Revised Impact of Event Scale
A 13-item measure of post-traumatic stress symptoms in reference to a recent negative event, rated on a 4-point scale; Not at all (score of 0), Rarely (score of 1), Sometimes (score of 3), Often (score of 5). Minimum score: 0; Maximum score: 65. Higher scores indicate worse outcomes.
Measured: Pre-intervention (baseline), post-intervention (within 2 weeks of post intervention), 3 month follow up
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Aug 2022
- Study startSep 2022 (estimated)
- Primary completion30 Jun 2024 (estimated)
- Study completion30 Jun 2024 (estimated)
Why it stopped: Difficulties with recruitment
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (11)Papers the sponsor has linked to this study.
- Other trials for DepressionStudies of the same condition, open and under way.
- More trials run by King's College LondonThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Eligible participants will be randomised to an intervention group or the control group.
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 0 participants (actual)
Sponsor and investigators
- Lead sponsor
- King's College London
- Sponsor type
- University, hospital or other
- Collaborators
- Mental Health Research UK
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05507385
- Sponsor's protocol ID
- IMAGINE-POSITIVE
- Acronym
- IMAGINE-P
- Status last verified
- May 2022
- First submitted
- 20 May 2022
- Last updated
- 9 Mar 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: No plan for individual participant data
Publications
Zisook S, Lesser I, Stewart JW, Wisniewski SR, Balasubramani GK, Fava M, Gilmer WS, Dresselhaus TR, Thase ME, Nierenberg AA, Trivedi MH, Rush AJ. Effect of age at onset on the course of major depressive disorder. Am J Psychiatry. 2007 Oct;164(10):1539-46. doi: 10.1176/appi.ajp.2007.06101757.
PubMed 17898345Bridge JA, Birmaher B, Iyengar S, Barbe RP, Brent DA. Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder. Am J Psychiatry. 2009 Jan;166(1):42-9. doi: 10.1176/appi.ajp.2008.08020247. Epub 2008 Dec 1.
PubMed 19047322Gabbay V, Johnson AR, Alonso CM, Evans LK, Babb JS, Klein RG. Anhedonia, but not irritability, is associated with illness severity outcomes in adolescent major depression. J Child Adolesc Psychopharmacol. 2015 Apr;25(3):194-200. doi: 10.1089/cap.2014.0105. Epub 2015 Mar 24.
PubMed 25802984Pizzagalli DA. Depression, stress, and anhedonia: toward a synthesis and integrated model. Annu Rev Clin Psychol. 2014;10:393-423. doi: 10.1146/annurev-clinpsy-050212-185606.
PubMed 24471371Giedd JN. The teen brain: insights from neuroimaging. J Adolesc Health. 2008 Apr;42(4):335-43. doi: 10.1016/j.jadohealth.2008.01.007.
PubMed 18346658Dunn BD. Helping depressed clients reconnect to positive emotion experience: current insights and future directions. Clin Psychol Psychother. 2012 Jul-Aug;19(4):326-40. doi: 10.1002/cpp.1799. Epub 2012 Jun 5.
PubMed 22674611Holmes EA, Blackwell SE, Burnett Heyes S, Renner F, Raes F. Mental Imagery in Depression: Phenomenology, Potential Mechanisms, and Treatment Implications. Annu Rev Clin Psychol. 2016;12:249-80. doi: 10.1146/annurev-clinpsy-021815-092925. Epub 2016 Jan 15.
PubMed 26772205Burnett Heyes S, Lau JY, Holmes EA. Mental imagery, emotion and psychopathology across child and adolescent development. Dev Cogn Neurosci. 2013 Jul;5:119-33. doi: 10.1016/j.dcn.2013.02.004. Epub 2013 Mar 5.
PubMed 23523985Pile V, Lau JYF. Looking forward to the future: Impoverished vividness for positive prospective events characterises low mood in adolescence. J Affect Disord. 2018 Oct 1;238:269-276. doi: 10.1016/j.jad.2018.05.032. Epub 2018 May 30.
PubMed 29894932Pile V, Smith P, Leamy M, Blackwell SE, Meiser-Stedman R, Stringer D, Ryan EG, Dunn BD, Holmes EA, Lau JYF. A brief early intervention for adolescent depression that targets emotional mental images and memories: protocol for a feasibility randomised controlled trial (IMAGINE trial). Pilot Feasibility Stud. 2018 Jul 4;4:97. doi: 10.1186/s40814-018-0287-3. eCollection 2018.
PubMed 29997904Lancaster GA, Dodd S, Williamson PR. Design and analysis of pilot studies: recommendations for good practice. J Eval Clin Pract. 2004 May;10(2):307-12. doi: 10.1111/j..2002.384.doc.x.
PubMed 15189396
Study at a glance
From the registry record, last updated by the sponsor on 9 Mar 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Brief Intervention Targeting Anhedonia in Adolescents: a Feasibility Randomised Controlled Trial
- ClinicalTrials.gov ID
- NCT05507385
- Acronym / sponsor ID
- IMAGINE-P / IMAGINE-POSITIVE
- Conditions
- Depression, Anhedonia
- Keywords
- Adolescence, Depression, Anhedonia, Mental Imagery
- Study type
- Interventional
- Recruitment status
- WithdrawnReason stopped: Difficulties with recruitment
- Enrolment
- 0 participants (actual)
- Lead sponsor
- King's College LondonUniversity, hospital or other
- Collaborators
- Mental Health Research UK
- Study start
- Sep 2022 (estimated)
- Primary completion
- 30 Jun 2024 (estimated)
- Study completion
- 30 Jun 2024 (estimated)
- First posted
- 19 Aug 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Depression is a common mental health problem that often begins during adolescence. Onset during adolescence can be disruptive to schoolwork and social relationships and if left untreated can lead to recurrence during adulthood, as well as the development of other mental health problems. Current treatments for depression (for both adults and young people) largely focus on reducing low mood and do not effectively tackle the other hallmark symptom of depression, anhedonia, which is characterised as a loss of enjoyment/ pleasure for previously enjoyed activities. Anhedonia is associated with increased risk of suicidality, so should be an important treatment target. Whilst some adult treatments are beginning to address anhedonia, little research has focussed on young people. It cannot be assumed that adult treatments will work identically in young people, particularly s their brains are still maturing compared to adults. The aim of this study is to complete a randomised feasibility trial, to see if it is possible to run a brief talking therapy for anhedonia in adolescent depression, by targeting one promising cognitive factor known to contribute to low positive affect: positive future mental imagery
Detailed description
The goal of the project is to develop a brief, manualised intervention for adolescent depression that targets anhedonia through harnessing the ability to imagine positive events. This intervention is designed to be delivered in the school environment by practitioners without extensive training. A feasibility randomised controlled trial (RCT) will be conducted by the doctoral student in the proposed project to assess the acceptability of this intervention in schools.
Principal Research Questions:
The primary question is whether a brief, structured intervention to reduce anhedonia symptomatology in depressed adolescents is feasible and acceptable. This trial will inform whether a full-scale efficacy trial is warranted and provide estimates of effect sizes. The trial's primary aims are:
- To evaluate recruitment and retention for a future efficacy RCT, for example recruitment rates for schools and participants, attrition rates and outcome measure completion.
- To gather descriptive data on symptom change to inform future estimates of the number of participants required for a fully powered efficacy RCT.
Background:
Depression is a major public health concern, associated with severe and long-lasting impairment. Many cases of depression start in adolescence with adolescent-onsets associated with greater illness burden than adult-onsets. Whilst psychological intervention in adolescence may prevent the persistence of depression into adulthood and its debilitating consequences, these are rarely available. There is also a consistent failure to produce well-replicated efficacious psychological and pharmacological treatments in adolescent depression. In adults, treatment innovation techniques have tried to focus on specific features, such as anhedonia, that are associated with severity and treatment response. Anhedonia, a loss of pleasure or lack of reactivity to pleasurable stimuli, is a hallmark feature of depression. It is associated with brain reward systems and, in youth, predicts illness severity, suicidality and poor treatment response better than other symptoms of depression. Given these findings and that brain reward systems underlying anhedonia are maturing and stabilising in adolescence focussing on the up-regulation of positive emotion during this developmental juncture could be a beneficial therapeutic approach.
Traditionally, psychological interventions for depression target negative affect in the present and/or past. However, potential deficits in processing positive information, in particular positive future-directed cognitions, may be crucial to alleviate anhedonia and produce enhanced treatment response. Mental imagery is suggested to be a powerful tool to promote changes in positive prospective cognitions. In adolescence, this approach could be particularly beneficial as it is a period when future orientation increases and when individuals rely more on imagery for processing and skill acquisition than in adulthood. Although research in this area in adolescent depression is limited, our findings suggest that having more vivid positive future imagery can protect against depressive symptoms in youth following a recent negative life event. Through a National Institute for Health and Care Research (NIHR) funded project, the investigators have developed a novel brief therapy manual and implementation protocol for adolescents using co-design methodology (Research Ethics Sub-Committee ref: HR-15/16-3548; Project ID: 14884). This targets mental imagery in general (rather than positive future mental imagery, in particular) to attenuate depression symptoms. A case series of 9 participants suggests that this intervention is acceptable and may have clinical utility. However, this intervention targets depression generally rather than anhedonia specifically and has only been delivered by an experienced child clinical psychologist. Therefore, the aim of this project is to develop a brief, manualised intervention that targets anhedonia in adolescents with depression, which can be delivered in schools by practitioners without extensive training.
Intervention:
The investigators will adapt our existing therapy manual to create a manualised protocol that more specifically targets positive future imagery to reduce anhedonia. The existing intervention is a four-session programme involving memory specificity training to increase specificity and access to autobiographical memories, imagery re-scripting to reduce distress from negative images and building of positive images. In order to tackle anhedonia more specifically, the investigators will replace negative imagery re-scripting with elements that target up-regulation of positive emotion and expand and elaborate on positive future imagery generation. These changes will also be informed through discussion with other experts and service-user consultants.
Feasibility randomised controlled trial: As this study will assess feasibility and not efficacy, a power calculation to determine sample size is not appropriate. The sample size (n=32, 16 in each arm) was determined with reference to good practice recommendations. The control condition will be 'non-directive supportive therapy', consisting of individual sessions to provide empathy and emotional support, discussion of participant-initiated options for addressing problems and monitoring of depression. The number and frequency of sessions will be matched across groups to control for non-specific factors contributing to change (e.g. passage of time, rapport with an empathic adult). Blind pre/post assessments will be conducted for all participants.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 2
- Model description
- Eligible participants will be randomised to an intervention group or the control group.
| Arm | Type | Receives |
|---|---|---|
| Intervention: IMAGINE-P | Experimental | Behavioral: IMAGINE-POSITIVEExperimental intervention: IMAGINE-POSITIVE targeting positive affect (IMAGINE-P): The intervention will combine aspects of Memory Specificity Training (MeST), which includes information about the links between memories and emotions, with Positive Prospective Mental Imagery (PPMI). |
| Control: | Active comparator | Behavioral: ControlControl intervention: Non-directive supportive therapy (NDST) consists of individual sessions, with an empathetic, emotionally supportive practitioner and provides non-directive problem solving and monitoring. Using NDST will control for factors that may contribute to change, which are not active components e.g. speaking to an empathetic therapist. NDST will follow treatment guidelines. |
Who may qualify
- Ages
- 14 to 19 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
Key inclusion criteria (4 listed)
- Aged 14-19
- Informed consent
- Willing and able to engage in psychological therapy and complete assessments
- scoring above clinical cut-off on the MFQ (33 items; clinical cut-off ≥20, and showing high symptoms of anhedonia, as measured by the SHAPS ( 14 items; abnormal level of hedonic tone>2).
Key exclusion criteria (6 listed)
- Diagnosis of learning disability (but not difficulty e.g. dyslexia), diagnosis of Autism Spectrum Disorder, or significant head injury, neurological disorder or epilepsy
- Unable to fluently communicate in spoken English
- Unable to give informed consent
- High levels of current risk
- Currently receiving therapy (including school counselling)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| IMAGINE-POSITIVEThe intervention will combine aspects of Memory Specificity Training (MeST), which includes information about the links between memories and emotions, with Positive Prospective Mental Imagery (PPMI), to increase vividness and savouring of positive future images, in order to harness positive affect. IMAGINE-PA will follow a treatment manual and delivery will be accompanied by a therapy workbook. | Behavioural | Intervention: IMAGINE-P |
| ControlNon-directive supportive therapy (NDST) consists of individual sessions, with an empathetic, emotionally supportive practitioner and provides non-directive problem solving and monitoring. Using NDST will control for factors that may contribute to change, which are not active components e.g. speaking to an empathetic therapist. NDST will follow treatment guidelines. | Behavioural | Control: |
Primary outcome
Feasibility outcome - 1: Uptake by schools
Time frame: Through study completion, an average of 9 months
A percentage will be calculated for: the number of schools that express interest in the study divided the number of schools that do take part.
Feasibility outcome - 2: Uptake by participants
Time frame: Through study completion, an average of 9 months
This will outcome will be assessed at the different stages of participant uptake: 1. the number of participants that completed the screen questionnaire divided by the number of students who received the screen questionnaire 2. the number of participants that accepted the invitation to pre-assessment divided by the number of participants that were eligible for pre-assessment from the screen 3. The number of participants randomised to intervention divided by the number of participants that completed the pre-assessment 4. The number of participants that completed the post-assessment divided by the number of participants that were randomised to intervention
Feasibility outcome - 3: Intervention completion
Time frame: Through study completion, an average of 9 months
The number of participants successfully completing the intervention
Feasibility outcome - 4: Intervention drop-out
Time frame: Through study completion, an average of 9 months
The number of participants that drop-out and the reasons for dropping out
Feasibility outcome - 5: Time Period
Time frame: Through study completion, an average of 9 months
Time needed to collect and analyse data
Feasibility outcome - 6: Data completeness at pre-assessment
Time frame: Through study completion, an average of 9 months
Data completeness for each questionnaire at pre-assessment
Feasibility outcome - 7: Missing Data at pre-assessment
Time frame: Through study completion, an average of 9 months
Data missing and reasons for missing data at pre-assessment
Feasibility outcome - 8: Data completeness at post-assessment
Time frame: Through study completion, an average of 9 months
Data completeness for each questionnaire at post-assessment
Feasibility outcome - 9: Missing Data at post-assessment
Time frame: Through study completion, an average of 9 months
Data missing and reasons for missing data at post-assessment
Feasibility outcome - 10: Data completeness at follow-up assessment
Time frame: Through study completion, an average of 9 months
Data completeness for each questionnaire at follow-up assessment
Feasibility outcome - 11: Missing Data at follow-up assessment
Time frame: Through study completion, an average of 9 months
Data missing and reasons for missing data at follow-up assessment
Feasibility outcome - 12: Unexpected adverse effects
Time frame: Through study completion, an average of 9 months
The number and nature of unexpected adverse effects will be recorded
Acceptability of the intervention - 1: Open questions for qualitative feedback of the programme
Time frame: Post-intervention (within 2 weeks of post intervention)
Qualitative questions on the feedback questionnaire: 1. What did you think of the programme? 2. Was there anything that made you more likely or less likely to take part in the programme? 3. How did you find completing the programme at school? 4. Was there anything about the programme that you really liked? 5. Was there anything about the training programme that you really didn't like? 6. What was the most important thing about the programme for you? 7. Would you recommend this to others who are experiencing difficulties with mood and self-esteem? If so why? Or why not? 8. Is there anything else you'd like to say about this programme?
Acceptability of the intervention - 2: Satisfaction with the programme
Time frame: Post-intervention (within 2 weeks of post intervention)
Participants indicate how satisfied they were with the programme on a 5-point scale; minimum score: 1; maximum score 5. Higher scores indicate better outcome.
Acceptability of the intervention - 3: Feedback on the number of sessions in the programme
Time frame: Post-intervention (within 2 weeks of post intervention)
Participants rate what they thought about the number of session on a 5-point scale. 1 = I would have liked 2+ less; 2= I would have liked 1-2 less; 3= I was happy with the number of sessions; 4= I would have liked 1-2 more; 5= I would have liked 2+ more. Minimum score: 1; maximum score 5.
Acceptability of the intervention - 4: Extend the programme has helped
Time frame: Post-intervention (within 2 weeks of post intervention)
Participants rate the extent to which the programme helped them on a 5-point scale. Minimum score: 1; maximum score: 5; higher scores indicate better outcome.
Acceptability of the intervention - 5: Recommend the programme to a friend
Time frame: Post-intervention (within 2 weeks of post intervention)
Participants rate if they would recommend the programme to a friend on a 5-point scale. 1= no, definitely not; 2= probably not; 3 = unsure; 4 = yes, probably; 5 = yes, definitely. Minimum score: 1; maximum score 5; higher scores indicate better outcome.
10 secondary outcomes
Mood and Feelings Questionnaire
Time frame: Pre-intervention (baseline), post-intervention (within 2 weeks of post intervention), 3 month follow up
Snaith-Hamilton Pleasure Scale
Time frame: Pre-intervention (baseline), post-intervention (within 2 weeks of post intervention), 3 month follow up
Positive and Negative Affect Schedule
Time frame: Pre-intervention (baseline), post-intervention (within 2 weeks of post intervention), 3 month follow up
The Prospective Imagery Task
Time frame: Pre-intervention (baseline), post-intervention (within 2 weeks of post intervention), 3 month follow up
Autobiographical Memory Task
Time frame: Pre-intervention (baseline), post-intervention (within 2 weeks of post intervention), 3 month follow up
Screen for Child Anxiety Related Disorders
Time frame: Pre-intervention (baseline), post-intervention (within 2 weeks of post intervention), 3 month follow up
Rosenberg Self Esteem Scale
Time frame: Pre-intervention (baseline), post-intervention (within 2 weeks of post intervention), 3 month follow up
Children's Response Style Questionnaire
Time frame: Pre-intervention (baseline), post-intervention (within 2 weeks of post intervention), 3 month follow up
Self Compassion Scale
Time frame: Pre-intervention (baseline), post-intervention (within 2 weeks of post intervention), 3 month follow up
Child Revised Impact of Event Scale
Time frame: Pre-intervention (baseline), post-intervention (within 2 weeks of post intervention), 3 month follow up
Results and safety
The study was withdrawn before enrolling participants, so there are no results.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Mar 2023.
- Background: PubMed 17898345Zisook S, Lesser I, Stewart JW, Wisniewski SR, Balasubramani GK, Fava M, Gilmer WS, Dresselhaus TR, Thase ME, Nierenberg AA, Trivedi MH, Rush AJ. Effect of age at onset on the course of major depressive disorder. Am J Psychiatry. 2007 Oct;164(10):1539-46. doi: 10.1176/appi.ajp.2007.06101757.
- Background: PubMed 19047322Bridge JA, Birmaher B, Iyengar S, Barbe RP, Brent DA. Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder. Am J Psychiatry. 2009 Jan;166(1):42-9. doi: 10.1176/appi.ajp.2008.08020247. Epub 2008 Dec 1.
- Background: PubMed 25802984Gabbay V, Johnson AR, Alonso CM, Evans LK, Babb JS, Klein RG. Anhedonia, but not irritability, is associated with illness severity outcomes in adolescent major depression. J Child Adolesc Psychopharmacol. 2015 Apr;25(3):194-200. doi: 10.1089/cap.2014.0105. Epub 2015 Mar 24.
- Background: PubMed 24471371Pizzagalli DA. Depression, stress, and anhedonia: toward a synthesis and integrated model. Annu Rev Clin Psychol. 2014;10:393-423. doi: 10.1146/annurev-clinpsy-050212-185606.
- Background: PubMed 18346658Giedd JN. The teen brain: insights from neuroimaging. J Adolesc Health. 2008 Apr;42(4):335-43. doi: 10.1016/j.jadohealth.2008.01.007.
- Background: PubMed 22674611Dunn BD. Helping depressed clients reconnect to positive emotion experience: current insights and future directions. Clin Psychol Psychother. 2012 Jul-Aug;19(4):326-40. doi: 10.1002/cpp.1799. Epub 2012 Jun 5.
- Background: PubMed 26772205Holmes EA, Blackwell SE, Burnett Heyes S, Renner F, Raes F. Mental Imagery in Depression: Phenomenology, Potential Mechanisms, and Treatment Implications. Annu Rev Clin Psychol. 2016;12:249-80. doi: 10.1146/annurev-clinpsy-021815-092925. Epub 2016 Jan 15.
- Background: PubMed 23523985Burnett Heyes S, Lau JY, Holmes EA. Mental imagery, emotion and psychopathology across child and adolescent development. Dev Cogn Neurosci. 2013 Jul;5:119-33. doi: 10.1016/j.dcn.2013.02.004. Epub 2013 Mar 5.
- Background: PubMed 29894932Pile V, Lau JYF. Looking forward to the future: Impoverished vividness for positive prospective events characterises low mood in adolescence. J Affect Disord. 2018 Oct 1;238:269-276. doi: 10.1016/j.jad.2018.05.032. Epub 2018 May 30.
- Background: PubMed 29997904Pile V, Smith P, Leamy M, Blackwell SE, Meiser-Stedman R, Stringer D, Ryan EG, Dunn BD, Holmes EA, Lau JYF. A brief early intervention for adolescent depression that targets emotional mental images and memories: protocol for a feasibility randomised controlled trial (IMAGINE trial). Pilot Feasibility Stud. 2018 Jul 4;4:97. doi: 10.1186/s40814-018-0287-3. eCollection 2018.
- Background: PubMed 15189396Lancaster GA, Dodd S, Williamson PR. Design and analysis of pilot studies: recommendations for good practice. J Eval Clin Pract. 2004 May;10(2):307-12. doi: 10.1111/j..2002.384.doc.x.
- Individual participant dataSharing planned: No. No plan for individual participant data
Related trials for Depression
Recruiting
Unified Protocol in Penitentiary Facilities
Depression Disorders, Anxiety
Not yet recruiting
Preventive and Personalized Digital Emotion Regulation Skills Intervention to Reduce Depression and Anxiety in Youths With Adverse Childhood Experiences
Adverse Childhood Experience, Depression / Major Depressive Disorder
Not yet recruitingObservational study
Functional Impact of Psychological Symptoms in Patients With Superior Semicircular Canal Dehiscence Syndrome (SSCD): a National Cross-sectional Study
Superior Semicircular Canal Dehiscence
Recruiting
Trial Phase: Syndemic Adapted Medly Uganda
Mental Health
Recruiting
Cultural Adaptation of an Online Parenting Intervention to Reduce the Risk of Depression and Anxiety in Adolescents
Risk of Depression and Anxiety
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing IMAGINE-POSITIVE in people with Depression and Anhedonia, run by King's College London at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: withdrawn, as of the sponsor's last update on 9 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was withdrawn before enrolling participants, so there are no results.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Feasibility outcome - 1: Uptake by schools (time frame: Through study completion, an average of 9 months). The study lists 17 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05507385, which also lists 11 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Mar 2023.